Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA.
Serum amyloid A (SAA), a plasma precursor of reactive amyloid deposits, is a multigene product. SAA1 and SAA2, with primary structures that are 93% identical (98 of 104 amino acids), behave as acute phase proteins, as demonstrated by their increasing levels in plasma. Heretofore, it has been understood that SAA1 predominates and functions as an isotype in plasma. However, accurate measurements differentiating the two isotypes have not been reported. In this study, using monoclonal antibodies specific for SAA1, we developed an enzyme-linked immunosorbent assay (ELISA) for SAA1. The levels and ratios of SAA1 in total SAA (TSAA) were investigated in healthy subjects and patients with rheumatoid arthritis (RA). The SAA1/TSAA ratio was 74 +/- 12% and 77 +/- 12% in healthy subjects and RA patients, respectively. In RA patients, the ratios were not influenced by SAA1 genotype, which has been proposed to affect plasma SAA values. The kinetics of SAA1 in inflamed patients undergoing hemodialysis was found to be parallel with total SAA and C-reactive protein. Finally, this study confirmed that SAA1 is a major isotype of acute phase SAA and may determine total SAA values. This specific assay could be used in the evaluation of SAA behavior in several clinical conditions.
Xu
Yuanyuan
Y
Department of Clinical Pathology, Juntendo University School of Medicine, Tokyo, Japan.
Yamada
Toshiyuki
T
Satoh
Takahiko
T
Okuda
Yasuaki
Y
D000210:Acute-Phase Reaction / Q000097:blood*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005838:Genotype; D006262:Health; D006801:Humans; D007249:Inflammation / Q000097:blood; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D020033:Protein Isoforms / Q000097:blood; D006435:Renal Dialysis; D000685:Serum Amyloid A Protein / Q000032:analysis*
D020033:Protein Isoforms; D000685:Serum Amyloid A Protein